Offer - Urjas Oil for just ₹ 1 X
Risnia MD 3 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Schizophrenia. Risnia MD 3 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Risnia MD 3 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Risnia MD 3 Tablet have been listed ahead. Usually, these side effects of Risnia MD 3 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Risnia MD 3 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. In addition, Risnia MD 3 Tablet's effects on the liver, heart and kidney are discussed below in the Risnia MD 3 Tablet related warnings section.
Individuals suffering from medical conditions like Tardive Dyskinesia, Kidney Disease, Liver Disease must refrain from the use of Risnia MD 3 Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Risnia MD 3 Tablet contraindications section.
Drug interactions for Risnia MD 3 Tablet have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Risnia MD 3 Tablet is considered not safe while driving, and is not addictive.
Risnia MD 3 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Risnia MD 3 Tablet safe for pregnant women?
Risnia MD can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Risnia MD right away. Take your doctor's advice before taking it again.
Is the use of Risnia MD 3 Tablet safe during breastfeeding?
Taking Risnia MD may lead to serious side effects if you are breastfeeding. Risnia MD should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Risnia MD 3 Tablet on the Kidneys?
Risnia MD rarely harms the kidneys.
What is the effect of Risnia MD 3 Tablet on the Liver?
Risnia MD is rarely harmful for the liver.
What is the effect of Risnia MD 3 Tablet on the Heart?
Risnia MD may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Risnia MD 3 Tablet unless your doctor advises you to do so -
Is this Risnia MD 3 Tablet habit forming or addictive?
Forming a habit of Risnia MD 3 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Risnia MD 3 Tablet. So it is best to avoid driving.
Is it safe?
Yes, but take Risnia MD 3 Tablet only as per medical advice.
Is it able to treat mental disorders?
Yes, taking Risnia MD 3 Tablet can treat mental disorders.
Interaction between Food and Risnia MD 3 Tablet
Some foods when eaten with Risnia MD 3 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Risnia MD 3 Tablet
Taking Risnia MD 3 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Risperdal® (risperidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 441-442
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1101-1103